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Background: In 2010, India accounted for 65,500 (47%) of the 139,300 measles-related deaths that occurred
globally. Data on the quality of age-appropriate measles vaccination in rural India is sparse. We explored the
following issues: (i) What proportion of Indian children were appropriately vaccinated against measles at 9 months
of age, and DPT-3 at 4 months? (ii) Which health facilities administered measles vaccine to children prior to
9 months of age and DPT-3 prior to 14 weeks?
Methods: We analyzed data from the 2008 Indian District Level Health Survey (DLHS-3) to determine the extent of
age-appropriate measles and DPT-3 vaccinations. Among 192,969 households in the dataset, vaccination cards with
detailed records were available for 18,670 children aged between 12 and 23 months.
Results: Among this cohort, 72.4% (13,511 infants) had received the first dose of measles vaccine. Only 30% of
vaccinated infants received the measles vaccine at the recommended age of 9 months. Similarly, only 31% of
infants in the cohort received DPT-3 vaccine at the recommended age of 14 weeks. About 82% of all prematurely
vaccinated children were vaccinated at health sub-centres, ICDS and Pulse Polio centres.
Conclusions: Age-inappropriate vaccination impacts adversely on the effectiveness of India’s measles immunisation
program due to sub-optimal seroconversion, if premature, and increased vulnerability to vaccine preventable
diseases, if delayed. Capacity building approaches to improve age-appropriate vaccination are discussed.
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It is generally advised that (except during an ongoing
measles epidemic) children should not be vaccinated
against measles until nine months of age, as vaccination
prior to this may result in the neutralization of vaccine
by maternal antibodies. In India and in most developing
nations, the recommended time for administering the
first dose of measles vaccine is 9 months [1]. In most de-
veloped nations, measles vaccine is typically adminis-
tered at a minimum age of 12 months [2], although
Australia’s government recently revised its childhood
immunisation program to reschedule the first dose of
measles-containing vaccine to 18 months (instead of
12 months) with effect from 1 July 2013. A major reason* Correspondence: niyi.awofeso@uwa.edu.au
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reproduction in any medium, provided the orfor deferring measles vaccine to at least 9 months of age is
due to evidence of low measles post-vaccination serocon-
version rates if vaccination is given before six months, and
optimal seroconversion rates if vaccination is delayed until
12 months, with as low as 36% protection afforded by
measles vaccination at 4–6 months of age [3]. Halsey
et al’s landmark study of measles vaccine seroconversion
among Haitian children, showed that seroconversion rate
at 6 months of 45% increased to a seroconversion rate of
100% at 12 months [4]. While global coverage of DPT-3
has increased from 20% in 1980 to 83% in 2011, 32% of
children who did not receive the DPT-3 as scheduled were
from India [5]. Measles and DPT-3 vaccinations constitute
reliable parameters for monitoring age-appropriate vac-
cination of childhood immunisation in India.
Although some researchers have suggested giving the
first dose of measles vaccination at seven months [6] or
giving vaccine doses at 4.5 months and then at 9 months
in high prevalence regions, lowering the timing of firstal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nificantly reduce all-cause mortality at age three years
(at least among boys), compared with a single measles
vaccine administered at 9 months following birth [7].
Moreover, logistic and cost implications of a two-part
first measles dose strategy may be prohibitive for most
poor nations who are currently unable to deliver the first
dose of vaccine to over 90% of eligible children.
The level of immunity that children under nine
months possess varies considerably depending on
whether the mother acquired measles immunity via vac-
cination or natural infection [8-10], and on antibody
variability in the infant [11]. Poor and undernourished
children tend to acquire many infections at an early age,
and passively acquired maternal antibody is neutralized
earlier than among economically advantaged children,
particularly in countries where low vaccine coverage
does not offer herd immunity [11,12]. The 2008 Indian
District Level Health Survey (DLHS-3) has documented
that 67% of 1-year old rural Indian children have re-
ceived first-dose measles immunization coverage, while
the 2009 Coverage Evaluation Survey reported the na-
tional estimate for the first dose measles immunization
coverage as being 74%, with 78% coverage documented
for urban areas and 72% for rural areas [13]. The 29,808
estimated new cases of measles in 2010 and the 65,500
deaths from measles-related causes in India represent an
unsatisfactory burden of disease reduction compared
with the 2000 baseline [14]. However, both surveys re-
lied largely on self-reports of measles vaccination to de-
termine coverage rates. Studies on the reliability of
mothers’ recall of measles vaccination have produced
mixed results [15,16]. As the mothers’ recall data from
the DHLS-3 does not include information on the timing
of measles vaccination, we were limited in this study to
data available from vaccination cards. Health workers’
documentations however, provide objective evidence of
vaccination and reduce the possibility of recall errors.
Interestingly, although the 2009 Indian measles immu-
nization coverage of 74% is close to the average measles
coverage for the South East Asia region of 78%, India
accounted for 58% of all measles cases in the South-East
Asian region in 2009 [17]. The fact that measles out-
breaks continue to occur in Indian districts with high
measles vaccination coverage [18] highlight the adverse
impact of low vaccine efficacy on measles control. Apart
from reduction or loss of vaccine potency due to the
failure of the cold chain system [19], low vaccination
coverage (particularly among vulnerable populations
such as slum dwellers) and inadequate surveillance,
age-inappropriate vaccination is a major constraint in
optimising measles and DPT vaccination outcomes in
India [20,21]. The Millennium Development Goal indi-
cator 4.3 for measles immunization coverage refers tothe proportion of one-year old children (i.e. 12 – 23 -
months old) immunized against measles [22]. In 2008,
the Indian National Technical Advisory Group on
Immunization recommended the introduction of a sec-
ond dose of measles-containing vaccine, delivered
through routine vaccination in states with ≥80% cover-
age with the first dose of measles-containing vaccine, or
through mass vaccination campaigns in states with
<80% measles containing vaccine coverage. Based on
these recommendations, the Government of India initi-
ated a second-dose measles vaccination in late 2010, to
be given anytime from eight weeks following the first
dose [1]. However, progress is slow not only because
only a minority of Indian districts have achieved over
80% measles vaccination coverage, but also because glo-
bal measles funding has declined from $US150 million
in 2007 to $US35 million in 2010, leading to postpone-
ment of scheduled vaccination campaigns [23].
Given the critical influence of the timing of vaccination
on measles incidence and mortality, we analysed the tim-
ing of measles vaccination among a sample of Indian chil-
dren with vaccination cards, using the nationally
representative DLHS-3 dataset. To examine if findings on
age-appropriateness of measles vaccination apply to other
vaccinations, we analysed the age-appropriateness of the
Diphtheria-Pertussis-Tetanus – 3rd dose (DPT-3) vaccin-
ation. This vaccine is scheduled to be administered at 14 -
weeks, according to India’s vaccination schedule [1]. We
sought to answer the following questions: (i) What pro-
portion of Indian children aged over 12 months were ad-
ministered the first dose of measles at 9 months of age,
and the third dose of DPT at 4 months of age? (ii) For chil-
dren that were administered the first dose of measles vac-
cine prior to 9 months of age, and the third dose of DPT
prior to 4 months of age, which health facilities adminis-
tered the vaccine? (iii) How can monitoring of measles
vaccination be improved to ensure that vaccination is ad-
ministered age-appropriately?
Methods
The 2008 DLHS-3 was collected by the International In-
stitute for Population Sciences, Mumbai on behalf of the
Ministry of Health and Family Welfare, Government of
India. All data were de-identified. The de-identified ver-
sion of the DLHS-3 data is publicly available upon for-
mal request for access to the Director of India’s Institute
of Population Sciences. As no patient could be identified
or contacted, no ethics approval was required by individ-
ual researchers to undertake this study.
The Immunization and Child Care Section (Section 3)
of the DLHS-3 survey records immunization history of
the last two surviving children. It also contains informa-
tion on the place of vaccination. All women who had
given birth in the five years prior to the survey were
Table 1 Timing of measles vaccination – DLHS-3
Vaccination age No. of children Percent Cumulative percent
0 71 0.53 0.53
1 41 0.3 0.83
2 56 0.41 1.24
3 65 0.48 1.72
4 87 0.64 2.37
5 117 0.87 3.23
6 158 1.17 4.4
7 327 2.42 6.82
8 1,084 8.02 14.85
9 4,011 29.69 44.53
10 3,608 26.7 71.24
Awofeso et al. BMC Public Health 2013, 13:358 Page 3 of 7
http://www.biomedcentral.com/1471-2458/13/358asked about the immunization status of their last two
surviving children. Using this data, we determined the
age of the child at the time of vaccination, and the place
of the vaccination.
There are 46,362 children aged between 12–23 months
in DLHS-3, of whom 18,670 (40%) were able to show
their vaccination card (recorded by Indian health
workers), 14,451 (31%) claimed to have a card but were
unable to produce them and the remaining 13,281 (29%)
did not have a card. As the dataset did not include
mothers’ self-reports of timing of their children’s vacci-
nations, only data on the 18,670 children with filled out
cards were used to determine age-appropriateness, and
the place where measles and DPT-3 vaccinations were
administered.11 1,599 11.83 83.07
12 872 6.45 89.53
13 473 3.5 93.03
14 286 2.12 95.14
15 219 1.62 96.77
16 123 0.91 97.68
17 97 0.72 98.39
18 75 0.56 98.95
19 54 0.4 99.35
20 42 0.31 99.66
21 29 0.21 99.87
22 14 0.1 99.98
23 3 0.02 100
Total 13,511 100
Source: DLHS-3.Results
Of the 18,670 children with verifiable vaccination cards,
72% received the first dose of measles vaccination. This
figure is identical to that obtained in the 2009 Coverage
Evaluation Survey, but higher than the 68% vaccination
coverage when self-reported vaccinations are included.
The vaccination coverage is also much lower than the
83% global measles vaccination coverage in 2008 [14].
Similar trends were noted for DPT-3 vaccination. Of
18,670 eligible children, 82% were vaccinated with DPT-
3, compared with 72% DPT-3 vaccination rate in the
2009 Coverage Evaluation Survey [13], and 83% global
DPT-3 vaccination coverage in 2011 [5].
Table 1 shows the proportion of children in our sam-
ple vaccinated against measles at specified months. Only
30% of one-year olds received the first dose of measles
vaccine at the appropriate age of 9 months.
Apart from the 28% of the children in the sample who
were not vaccinated against measles, about 7% of chil-
dren in the sample received the first dose of measles
vaccine after 12 months of age. During this period, such
children are vulnerable to measles infection as they lack
maternal antibodies. Furthermore, a high proportion of
rural-based Indian infants are malnourished, thus mak-
ing them more vulnerable to measles infection. Since
most Indian regions have generally low measles vaccin-
ation coverage (< 85%), the median age of measles infec-
tion is low, and the median attack rate of measles is high
among these children [24]. Similar age-inappropriate
trends were observed for DPT-3 vaccination (Table 2),
with only 31% vaccinated with DPT-3 in the fourth
month as recommended by India’s childhood immu-
nization schedule. About 14% of all children with docu-
mented cards were given DPT at or prior to, the
12 week, although the vaccine was due to be adminis-
tered by the 14th week, and preferably no later than the
16th week [1].Indian health workers involved with vaccination pro-
grams are expected to be familiar with the vaccination
schedule, and not vaccinate any child against measles
prior to nine months of age or, for DPT-3, prior to the
4th month.
Data on the place of measles vaccination presented in
Table 3 show that 82% of all prematurely administered
vaccinations were delivered at three venues: the Sub-
centers, Integrated Child Development Services (i.e.
Anganwadi) and Pulse Polio Centers. Of the 4,011
children that received the age-appropriate vaccinations
at 9 months of age, only 55% were vaccinated at these
centres.
Table 3 shows that competency deficiencies (assessed
in this study by proportion of prematurely vaccinated
children) affect both the public and private health sec-
tors in India, but are most marked amongst the typically
less technically qualified staff (including volunteers) who
work in Sub-health centres, Pulse Polio and Anganwadi
centers [25,26]. Age-inappropriate vaccination for mea-
sles is a major health risk for affected children. Parents
Table 2 DPT-3 vaccination by age, in months
Vaccination age No. of children Percent Cumulative percent
0 58 0.38 0.38
1 78 0.51 0.89
2 336 2.19 3.07
3 1,671 10.88 13.95
4 4,767 31.03 44.98
5 3,187 20.75 65.73
6 1,753 11.41 77.14
7 982 6.39 83.54
8 658 4.28 87.82
9 499 3.25 91.07
10 356 2.32 93.39
11 255 1.66 95.05
12 209 1.36 96.41
13 126 0.82 97.23
14 103 0.67 97.9
15 94 0.61 98.51
16 92 0.6 99.11
17 42 0.27 99.38
18 45 0.29 99.67
19 18 0.12 99.79
20 22 0.14 99.93
21 8 0.05 99.99
23 2 0.01 100
Total 15,361 100
Source: DLHS-3.
Table 3 Percentage of children vaccinated prematurely
against measles by place of vaccination





















Ayush hospital/clinic 0.22 0.20
Private Health facilities




Private hospital 5.55 4.56
Private doctor/clinic 1.19 1.36





Awofeso et al. BMC Public Health 2013, 13:358 Page 4 of 7
http://www.biomedcentral.com/1471-2458/13/358of children vaccinated before six months of age are
lulled into a false sense of security, although their
children remain at risk of measles infection. Failure to
vaccinate against measles not only increases the risk of
measles-related morbidity and mortality, but may also
significantly increase the risk of all-cause mortality [27].
The unsatisfactory level of measles vaccination docu-
mentation – less than 20% of one year olds in DLHS-3
have filled out vaccination cards - is a crucial indicator
of poor measles vaccination surveillance in India [28,29].
Discussion
Our review reveals three important weaknesses in India’s
childhood vaccination program: (i) poor quality surveil-
lance and documentation of childhood immunization
data; (ii) sub-standard indicators for vaccination quality
monitoring (the extent that MDG indicator for adequacy
of measles immunisation currently in use is not sensitive
enough to determine premature measles vaccination as
well as delayed vaccination prior to 23 months); (iii) in-
adequate training, competency, or supervision of some
of the staff administering measles vaccination, asevidenced by the majority of premature vaccination tak-
ing place in centres where health workforce is least
trained. For example, a Sub-health centre is typically
staffed by one Female Health Worker commonly known
as Auxiliary Nurse Midwife (ANM) and one Male
Health Worker commonly known as Multi-Purpose
Worker. Although there are documented minimum
standards of care expected of staff at the Sub-health cen-
tres [30], there is no minimum standard of training or
qualifications required to work in sub-health centres, the
most peripheral and first contact point between the pri-
mary health care system and the community.
Optimising age-appropriate vaccination is a major pri-
ority for effective delivery of immunizations in India
[31,32]. Data on India’s measles statistics from the
South-East Asian Regional office, reveals that there have
been no formal surveillance studies on nationwide mea-
sles morbidity and mortality since 2005 [30]. Poor docu-
mentation of vaccination data inevitably results in
erroneous estimates. While the WHO data focusses on
children immunized by 12– 23 months of age, vaccin-
ation given prior to 6 months of age is very likely to be
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measles vaccine recipients at 4–6 months of age are vul-
nerable to infection due to neutralization by maternal
antibodies [3]. Children immunized following 12 months
of birth are not protected by maternal antibodies after
one year of birth, and are vulnerable to wild measles in-
fection, given the absence of herd immunity [33]. The
longer such immunization is delayed, the greater is the
risk of severe measles infection.
In rural India, with 72% of the vulnerable population
immunized against measles, it is not surprising that case
fatality rate is high, and the average age of infection is
concentrated in the first three years of life [34]. Simi-
larly, given that child morbidity (India reported 26,044
cases of pertussis in 2005) and mortality from pertussis
is high among infected children who have not completed
their third dose of vaccination prior to six months of age
[35,36], the fact that only 77% of children received the
third dose of DPT vaccine by the end of the sixth month
(Table 2) highlights the potential adverse health conse-
quences of delays in timing childhood immunizations in
India.
The MDG indicator 4.3 for measles immunization
coverage [22] fails to distinguish between those vacci-
nated prior to six months, those vaccinated between
12 and 23 months, and those vaccinated in age-
appropriately. It is acknowledged that the MDG indica-
tors were consensus instruments designed to optimise
ease of measurement and global acceptance, however,
as measles prevalence falls and the 2015 post MDG era
approaches, it is important to refine this indicator in
order to improve program outcomes. A more sensitive
age-appropriate indicator of measles immunization
coverage might read; “the percentage of children aged
12 – 23 months who were vaccinated at 9 months of
age”.
Our data indicates that coverage with first dose of
measles vaccine was ≥ 90% in only 26% of the evaluated
Indian districts. State-level coverage for the first dose of
measles vaccine ranges between 48% to 96% [33]. The
wide variability in program outcomes mirrors asymmet-
ries in the quality of measles vaccination program man-
agement in various districts of India.
Table 3 shows that 38.6% of all premature measles vac-
cinations (i.e. vaccination prior to the age of 9 months)
took place in Integrated Child Development Centers (i.e.
Anganwadi), and maybe in part due to their inadequate
education and competency level, and in line with their
sub-optimal performance in the nutrition and health
education components of the program [37]. Apart from
very low seroconversion rates, premature administration
of measles vaccine may also result in infants receiving
DPT vaccination following measles vaccination, a factor
associated with high female mortality [38]. This mayimply that the task shifting of measles vaccination activ-
ities to the least trained and supervised health staff (who
vaccinated 77% of all children against measles in the
analysed data) may be compromising the quality of mea-
sles vaccination in India, thus contributing to the
current unsatisfactory trends in measles vaccination and
consequently high measles morbidity and mortality.
India’s Universal Immunisation program has been
performing sub-optimally over the past decade, with aver-
age national immunisation coverage in 2009 reported as
being 61%, and a wide range of vaccination coverage
between states, the highest coverage recorded in Goa
(88%) and the lowest in Nagaland (27%) [39]. The reasons
for poor age-specific timing of measles vaccination are
also related to India’s poorly functioning public health
system [40,41].
This study has several limitations. First, it is focused
on children with documented vaccination cards as this is
the only cohort for whom there is information on the
timing of vaccination. We acknowledge that the exclu-
sion of children with no documented vaccination cards
may limit the applicability of our findings to the general
Indian population. Second, we have focused on service
factors affecting sub-optimal vaccination. While it is
possible that structural determinants such as gender,
socio-economic factors and access to vaccination centres
may influence age-inappropriate vaccination, neverthe-
less, we believe that the impact of such social determi-
nants would deviate from the key point that we want to
make in this paper on the crucial role of the service pro-
viders in vaccinating appropriately. Third, we have no
data on the training, supervision or competencies of staff
in Sub-health centres, Pulse Polio centres and ICDS cen-
tres during the period DLHS-3 data were collected in
those centres. Our observations and comments on these
centres are based on secondary data [42] as well as on
field visits in 2012 to a sample of these centres, and may
therefore differ from the actual workforce and program
management situation in these centres in 2008 when
data for our study were collected.
Conclusion
This study reveals that India’s 2008 measles vaccination
coverage in rural areas was 72%, based on documented
information from vaccination cards. Among those vacci-
nated, age-inappropriate vaccination is common and a
major factor contributing to India’s disproportionately
high measles morbidity and mortality in 2010. Age-
inappropriate vaccination practices associated with mea-
sles are reflected in DPT-3 vaccination, making it likely
that such deficiencies affect all childhood vaccinations.
We suggest a three-pronged approach to improve age
appropriateness of measles immunization in India; im-
proving surveillance and documentation systems so as
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at the optimal age range; refining measles vaccination
coverage indicators to better define the proportion of
children who have received the first dose of measles vac-
cine at the appropriate of 9 months, and; improving
measles vaccination program management and supervi-
sion, particularly in the locations where vaccines are be-
ing delivered prematurely, as well as in the 74% of
districts with less than 90% immunization coverage by
age 23 months. The successful eradication of polio in
India in 2012 highlights the possibilities for measles
eradication if concerted efforts are made to improve the
quality and coverage of measles immunization. Assuring
age appropriate measles vaccination is an important
quality indicator in this regard.
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